| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease
|
Lim, Yen Ying
|
|
|
10 |
6 |
p. 743-751.e1
|
artikel
|
| 2 |
A comparison of neuropsychological performance between US and Russia: Preparing for a global clinical trial
|
Hayden, Kathleen M.
|
|
|
10 |
6 |
p. 760-768.e1
|
artikel
|
| 3 |
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|
Jessen, Frank
|
|
|
10 |
6 |
p. 844-852
|
artikel
|
| 4 |
African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles
|
Roses, Allen D.
|
|
|
10 |
6 |
p. 592-601.e2
|
artikel
|
| 5 |
Alzheimer's Association Update
|
|
|
|
10 |
6 |
p. 883-884
|
artikel
|
| 6 |
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
|
Sattlecker, Martina
|
|
|
10 |
6 |
p. 724-734
|
artikel
|
| 7 |
Alzheimer's disease public-private partnerships: Update 2014
|
Snyder, Heather M.
|
|
|
10 |
6 |
p. 873-880
|
artikel
|
| 8 |
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
|
Langbaum, Jessica B.
|
|
|
10 |
6 |
p. 666-674
|
artikel
|
| 9 |
APOE ε4 and risk for Alzheimer's disease: Do regionally distributed white matter hyperintensities play a role?
|
Brickman, Adam M.
|
|
|
10 |
6 |
p. 619-629
|
artikel
|
| 10 |
APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia
|
Josephs, Keith A.
|
|
|
10 |
6 |
p. 630-636
|
artikel
|
| 11 |
APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
|
Michaelson, Daniel M.
|
|
|
10 |
6 |
p. 861-868
|
artikel
|
| 12 |
A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease
|
Barnes, Deborah E.
|
|
|
10 |
6 |
p. 646-655
|
artikel
|
| 13 |
A presenilin 1 mutation in the first case of Alzheimer's disease: Revisited
|
Rupp, Carsten
|
|
|
10 |
6 |
p. 869-872
|
artikel
|
| 14 |
Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?
|
Snyder, Peter J.
|
|
|
10 |
6 |
p. 853-860
|
artikel
|
| 15 |
Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease
|
Dodge, Hiroko H.
|
|
|
10 |
6 |
p. 690-703
|
artikel
|
| 16 |
Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer's disease?
|
Tarnanas, Ioannis
|
|
|
10 |
6 |
p. 790-798
|
artikel
|
| 17 |
Contents
|
|
|
|
10 |
6 |
p. A1-A4
|
artikel
|
| 18 |
Development and validation of a brief dementia screening indicator for primary care
|
Barnes, Deborah E.
|
|
|
10 |
6 |
p. 656-665.e1
|
artikel
|
| 19 |
Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery
|
Mathews, Melissa
|
|
|
10 |
6 |
p. 675-683
|
artikel
|
| 20 |
Editorial
|
Khachaturian, Ara S.
|
|
|
10 |
6 |
p. 590-591
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
10 |
6 |
p. A5
|
artikel
|
| 22 |
Extension and refinement of the predictive value of different classes of markers in ADNI: Four-year follow-up data
|
Gomar, Jesus J.
|
|
|
10 |
6 |
p. 704-712
|
artikel
|
| 23 |
Genetic modification of the relationship between phosphorylated tau and neurodegeneration
|
Hohman, Timothy J.
|
|
|
10 |
6 |
p. 637-645.e1
|
artikel
|
| 24 |
Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging
|
Mielke, Michelle M.
|
|
|
10 |
6 |
p. 779-789
|
artikel
|
| 25 |
Issues about the use of subjective cognitive decline in Alzheimer's disease research
|
Canevelli, Marco
|
|
|
10 |
6 |
p. 881-882
|
artikel
|
| 26 |
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease
|
Alexopoulos, Panagiotis
|
|
|
10 |
6 |
p. 684-689
|
artikel
|
| 27 |
Medical and Scientific Advisory Council
|
|
|
|
10 |
6 |
p. A7
|
artikel
|
| 28 |
Neural correlates of empathic impairment in the behavioral variant of frontotemporal dementia
|
Cerami, Chiara
|
|
|
10 |
6 |
p. 827-834
|
artikel
|
| 29 |
Plasma proteins predict conversion to dementia from prodromal disease
|
Hye, Abdul
|
|
|
10 |
6 |
p. 799-807.e2
|
artikel
|
| 30 |
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia
|
Slattery, Catherine F.
|
|
|
10 |
6 |
p. 602-608.e4
|
artikel
|
| 31 |
Social cognition in Alzheimer's disease: A separate construct contributing to dependence
|
Cosentino, Stephanie
|
|
|
10 |
6 |
p. 818-826
|
artikel
|
| 32 |
Subjective cognitive concerns, episodic memory, and the APOE ε4 allele
|
Samieri, Cécilia
|
|
|
10 |
6 |
p. 752-759.e1
|
artikel
|
| 33 |
Subscriber information
|
|
|
|
10 |
6 |
p. A9
|
artikel
|
| 34 |
The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?
|
Duits, Flora H.
|
|
|
10 |
6 |
p. 713-723.e2
|
artikel
|
| 35 |
The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
|
Molinuevo, José Luis
|
|
|
10 |
6 |
p. 808-817
|
artikel
|
| 36 |
The effects of cognitive impairment on nursing home residents' emergency department visits and hospitalizations
|
Stephens, Caroline E.
|
|
|
10 |
6 |
p. 835-843
|
artikel
|
| 37 |
The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics
|
Beeri, Michal Schnaider
|
|
|
10 |
6 |
p. 769-778
|
artikel
|
| 38 |
Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample
|
Bilgel, Murat
|
|
|
10 |
6 |
p. 735-742.e4
|
artikel
|
| 39 |
Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans
|
Logue, Mark W.
|
|
|
10 |
6 |
p. 609-618.e11
|
artikel
|
| 40 |
Why a woodpecker?
|
Khachaturian, Ara S.
|
|
|
10 |
6 |
p. 587-589
|
artikel
|
Tijdschrift beschrijving